# Polymorphisms at Distinct Genetic Loci Affect Response to Anti-CD20 Monoclonal Antibody Therapies

> **NCT02694913** · — · COMPLETED · sponsor: **Weill Medical College of Cornell University** · enrollment: 82 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **OTHER:** Non Interventional

## Key facts

- **NCT ID:** NCT02694913
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2019-02-07
- **Final completion:** 2019-02-07
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2020-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02694913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02694913, "Polymorphisms at Distinct Genetic Loci Affect Response to Anti-CD20 Monoclonal Antibody Therapies". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02694913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*